Google
×
Renalytix is an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved ...
LONDON and SALT LAKE CITY, April 08, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces a registered direct offering of ordinary ...
Missing: relations | Show results with:relations
People also ask
Investor Newsletter. To receive Investor News as it is released ... RENX) , in accordance with Rule 2.9 of the City ... Annual & Half Year Reports ˇ Shareholder ...
Missing: relations | Show results with:relations
Renalytix (LSE: RENX) (NASDAQ: RNLX) is the founder and global leader in the new field of bioprognosis™ for kidney health. They've engineered a new solution ...
Jun 24, 2021 ˇ Communicating with investors has always been vital, but the pandemic both created a greater deman... ˇ Fiera Real Estate ˇ NYX Capital Corp.
Renalytix jumps on Middle East distribution deal, 'region with most diabetes globally' ... Renalytix PLC (AIM:RENX) shares ramped 7.5% higher to 128.95p on Friday ...
Missing: relations | Show results with:relations
RENALYTIX PLC RENX Company page - Search stock, chart, recent trades, company information, trading information, company news, fundamentals.
Latest Renalytix PLC (RENX:LSE) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.
Find the latest Renalytix Plc (RENX.L) stock quote, history, news and other vital information to help you with your stock trading and investing.